Back to top

consumer-staples: Archive

Zacks Equity Research

Is PepsiCo's Margin Outlook Improving Despite Tariff Cost Pressures?

PEP aims to boost margins through cost cuts, automation and global productivity, despite ongoing pressures and uneven segment performance.

Zacks Equity Research

Will PG's Focus Markets Offset Weakness in Baby Care and China?

Procter & Gamble leans on Focus Markets for growth, with China improving, Europe mixed results and Baby Care innovation aimed at offsetting softer demand.

Zacks Equity Research

Is Colgate's Productivity Program a Catalyst for Its Margins?

CL's productivity program is easing cost pressures and paving the way for mid-25% margins, balancing efficiency with brand investment.

Swagata Bhattacharya

Is KMB's Brand Investment Strategy Enhancing Its Competitive Edge?

Kimberly-Clark's disciplined brand reinvestment is driving sustained volume-plus-mix growth, share gains, and margin expansion despite cost pressures.

Rajani Lohia

Coca-Cola's Story: Can Organic Growth Stay Resilient in 2026?

KO appears poised for organic growth at the high end of its model, gaining value share while leveraging pricing, volume and productivity amid macro pressures.

Jewel Saha

Fed Caution Ahead: 5 Low-Volatility Stocks to Buy for 2026

As Fed uncertainty looms, MNST, MAMA, D, AEE and SRE stand out as low-volatility picks with 2026 earnings growth in focus.

Mahak Lohia

Mango Momentum Builds: Will AVO Crack the Year-Round Supply Code?

Mission Produce's mango business gains traction as diversified sourcing and logistics aim to crack year-round supply, testing if mangoes can scale like avocados.

Mahak Lohia

Can NIKE's "Sport Offense" Reignite Growth Across Key Markets?

NKE is betting on its Sport Offense sport-led innovation and faster cycles to rebuild brand heat, fix channels and reignite growth across key markets.

Zacks Equity Research

Altria Nicotine Pouch Volumes Surge: Is Helix the Real Profit Driver?

MO's Helix Innovations is lifting oral tobacco results as nicotine pouch volumes climb, prices rise, and margins expand despite declines in other categories.

Santanu Roy

Take the Zacks Approach to Beat the Markets: Castle Biosciences, Hamilton Insurance & Monster Beverage in Focus

Castle Biosciences surged 77.9% after a Zacks upgrade, highlighting how the firm's stock picks outpaced the broader market in recent months.